A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index-Reference-Cited by-同舟云学术

A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index

Published:2012-07 Issue:1 Volume:62 Page:78-84
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Ulmert David,Kaboteh Reza,Fox Josef J.,Savage Caroline,Evans Michael J.,Lilja Hans,Abrahamsson Per-Anders,Björk Thomas,Gerdtsson Axel,Bjartell Anders,Gjertsson Peter,Höglund Peter,Lomsky Milan,Ohlsson Mattias,Richter Jens,Sadik May,Morris Michael J.,Scher Howard I.,Sjöstrand Karl,Yu Alice,Suurküla Madis,Edenbrandt Lars,Larson Steven M.

Publisher

Elsevier BV

Subject

Urology

Reference16 articles.

1. Spread of prostatic cancer to bone;Jacobs;Urology,1983

2. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan;Soloway;Cancer,1988

3. Stromal factors involved in prostate carcinoma metastasis to bone;Cooper;Cancer,2003

4. The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma;Carlin;Cancer,2000

5. Radionuclide based imaging of prostate cancer;Mease;Curr Top Med Chem,2010

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence in skeletal metastasis imaging;Computational and Structural Biotechnology Journal;2024-12

2. Quantitative single-photon emission computed tomography/computed tomography in assessing the effectiveness of radium-223 dichloride therapy;Cancer Urology;2024-08-15

3. SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases;Seminars in Nuclear Medicine;2024-05

4. Leveraging Model Scaling and Butterfly Network in the Bone Scan Image Segmentation;International Journal of Computational Intelligence Systems;2024-04-11

5. Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer;Cancers;2024-02-22